Calamos Wealth Management »

Biomarin Pharma Inc convertible/ shares owned by Calamos Wealth Management

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Calamos Wealth Management from 13F filings

Historical chart of Calamos Wealth Management investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Calamos Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Calamos Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $132k 134k 0.98
2023-12-31 $107k 108k 0.99
2023-09-30 $133k 137k 0.97
2023-06-30 $148k 150k 0.98
2023-03-31 $179k 175k 1.02
2022-12-31 $191k 180k 1.06
2022-09-30 $180k 181k 0.99

More positions owned by Calamos Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Ishares Tr S&p 500 Val Etf (IVE)
Microsoft Corporation (MSFT)
Ishares Tr S&p 500 Grwt Etf (IVW)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Ishares Tr Russell 3000 Etf (IWV)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Msci Acwi Ex Us (ACWX)
Vanguard Scottsdale Fds Long Term Treas (VGLT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Eli Lilly & Co. (LLY)
Marathon Digital Holdings In (MARA)

View all positions for Calamos Wealth Management

Top funds holding Biomarin Pharma Inc convertible/

Lord, Abbett & Co
Bank of America Corporation
Millennium Management
Citigroup
Aviva
Sona Asset Management
Tenor Capital Management
Shaolin Capital Management
Sunrise Partners Limited Partnership
Partner Fund Management
Moore Capital Management
Thrivent Financial for Lutherans
MacKay Shields
Jpmorgan Chase & Co
Palisade Capital Management

View all funds holding Biomarin Pharma Inc convertible/